Dupilumab Improves Daily Symptom Burden in Adult Patients with Prurigo Nodularis: Post Hoc Analysis from LIBERTY PN-PRIME and PRIME2 Studies

20260 citationsJournal Articlegold Open Access

Authors

Shawn G. Kwatra · University of Maryland, Baltimore

Sonja Ständer · University Hospital Münster

Brian S. Kim · Icahn School of Medicine at Mount Sinai

Jerome Msihid · Sanofi (France)

Ashish Bansal · Regeneron (United States)

Melanie Makhija · Sanofi (United States)

Simmi Wiggins

Abstract

Patients treated with dupilumab showed greater improvement in DSB with respect to itch, skin pain, and sleep disturbance than those receiving placebo.

Topics & Keywords

Dermatology and Skin Diseases Psoriasis: Treatment and Pathogenesis Hidradenitis Suppurativa and Treatments

Publication Details

Published in: Dermatology and Therapy

Volume 16, Issue 3, pp. 1767-1778

DOI: 10.1007/s13555-026-01674-5

Field-Weighted Citation Impact: 0.00

Command Palette

Dupilumab Improves Daily Symptom Burden in Adult Patients with Prurigo Nodularis: Post Hoc Analysis from LIBERTY PN-PRIME and PRIME2 Studies

Authors

Abstract

Topics & Keywords

Publication Details